Taurine per Difficoltà di addormentamento

Q: Does Taurine help with Difficoltà di addormentamento?

Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that Taurine may support Difficoltà di addormentamento management. Our evidence grade is B (Good Evidence).

Q: How much Taurine should I take for Difficoltà di addormentamento?

Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Taurine?

Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Taurine and Difficoltà di addormentamento?

We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

B Evidenze Almeno un trial randomizzato lo supporta, con risultati per lo più coerenti.

Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dtaurine\u0026condition\u003Dsleep\u002Donset\u002Dlatency'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

In sintesi

Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.

Key Study Findings

Controlled Clinical Trial n=32 12 weeks Open-label

Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …

Dose: None vs: Standard care alone Outcome: Itch and insomnia improvement in atopic dermatitis Effetto: None 0.0449 (itch), 0.0089 (insomni

Popolazione: Patients with atopic dermatitis and mild-moderate negative emotions

Other

Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.

Dose: None vs: None Outcome: None Effetto: None p < .05

Popolazione: Insomnia patients

Review

Commonly encountered symptoms and their management in patients with cirrhosis.

Dose: None vs: None Outcome: Pain outcomes Effetto: None None

Popolazione: Insomnia patients

Observational Study

[Energy drink consumption patterns and its adverse effects on adolescent health.].

Dose: None vs: None Outcome: Energy drink consumption and adverse effects Effetto: None None

Popolazione: Adolescents

Other

[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …

Dose: None vs: None Outcome: rat model of cardiorenal insomnia from in vitro … Effetto: None None

Popolazione: None

Review

Assessment and treatment of insomnia in adult patients with alcohol use disorders.

Dose: None vs: None Outcome: None Effetto: None None

Popolazione: insomnia patients

Key Statistics

Studi

Partecipanti

↔

Mixed

Grado

Referenced Papers

Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. Other

Asian Pacific journal … 2025 6 citazioni

Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. Other

PloS one 2024 5 citazioni

Commonly encountered symptoms and their management in patients with cirrhosis. Review

Frontiers in medicine 2024 4 citazioni

[Energy drink consumption patterns and its adverse effects on adolescent health.]. Other

Revista espanola de … 2022 2 citazioni

[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. Other

Zhongguo Zhong yao … 2020 5 citazioni

Assessment and treatment of insomnia in adult patients with alcohol use disorders. Review

Alcohol (Fayetteville, N.Y.) 2015 122 citazioni

The clinical pharmacology of acamprosate. Review

British journal of … 2014 111 citazioni

Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Systematic Review

Alcohol and alcoholism … 2011 40 citazioni

Safety issues associated with commercially available energy drinks. Review

Journal of the … 2008 300 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

sleep:: 500-2,000 mg, 1 hour before bed

Limite massimo: 3,000 mg/day considered safe in clinical studies

Dosaggi studiati nella ricerca

Dosaggio	Durata	Effetto	N
None	12 weeks	Positive	32
None	--	Neutral	--
None	--	Neutral	--
None	--	Mixed	--
None	--	Mixed	--
None	--	Positive	--
None	--	Positive	--
None	--	Mixed	--

Momento migliore per l'assunzione: 1 hour before bed

Safety & Side Effects

Effetti collaterali segnalati

⚠ Generally well tolerated
⚠ Mild GI discomfort at high doses
⚠ Drowsiness (desired for sleep use)

Interazioni note

● Lithium — taurine may alter lithium excretion
● Antihypertensives — may have additive blood pressure lowering effects
● CNS depressants — potential additive sedative effects

Livello di assunzione massimo tollerabile: 3,000 mg/day considered safe in clinical studies

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Taurine help with Difficoltà di addormentamento?

Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that Taurine may support Difficoltà di addormentamento management. Our evidence grade is B (Good Evidence).

How much Taurine should I take for Difficoltà di addormentamento?

Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Taurine?

Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Taurine and Difficoltà di addormentamento?

We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.

Altri ingredienti per Difficoltà di addormentamento

Vitamina B6 A Magnesio glicinato A Zinco A Melatonin A Hops A L-Theanine A

Taurine per altre condizioni

Insonnia B Nighttime Pain-Related Sleep Disruption B

Verdetto rapido

Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.

Evidence Strength72%

High confidence

Analisi degli studi

RCT (0)Meta (0)Other (9)

Confronta le alternative

Scoprite come si confrontano altri ingredienti per questa condizione.

Visualizza tutti gli ingredienti per Difficoltà di addormentamento

Approfondimenti

References

[1] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
[2] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
[3] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
[4] Paola Silva Maldonado et al.. Rev Esp Salud Publica. 2022. [Energy drink consumption patterns and its adverse effects on adolescent health.]. PubMed
[5] Yu-Han Yang et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. doi:10.19540/j.cnki.cjcmm.20190524.502 PubMed
[6] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
[7] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
[8] Bhanu Prakash Kolla et al.. Alcohol Alcohol. 2011. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. doi:10.1093/alcalc/agr073 PubMed
[9] Kevin A Clauson et al.. J Am Pharm Assoc (2003). 2008. Safety issues associated with commercially available energy drinks. doi:10.1331/JAPhA.2008.07055 PubMed

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.

Taurine per Difficoltà di addormentamento

Embed This Widget

In sintesi

Key Study Findings

Key Statistics

Referenced Papers

Dosage & Usage

Dosaggi di uso comune

Dosaggi studiati nella ricerca

Safety & Side Effects

Effetti collaterali segnalati

Interazioni note

Frequently Asked Questions

Related Evidence

Altri ingredienti per Difficoltà di addormentamento

Taurine per altre condizioni

References